Lilly signs licensing agreements with Dr Reddy’s, MSN Labs and Torrent Pharma for Baricitinib Read more
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India Read more
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase III trial Read more
